Squadron Capital Management »

Proqr Thrapeutics N V shs euro shares owned by Squadron Capital Management

Quarter-by-quarter ownership of Proqr Thrapeutics N V shs euro (PRQR) shares owned by Squadron Capital Management from 13F filings

Historical chart of Squadron Capital Management investment in Proqr Thrapeutics N V shs euro

Tip: Access up to 7 years of quarterly data

All positions including Proqr Thrapeutics N V shs euro held by Squadron Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Proqr Thrapeutics N V shs euro by Squadron Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.8M 1.5M 1.86

More positions owned by Squadron Capital Management

Relmada Therapeutics (RLMD)
C4 Therapeutics Com Stk (CCCC)
Cogent Biosciences (COGT)
Zentalis Pharmaceuticals Call Option (ZNTL)
Kodiak Sciences (KOD)
Relay Therapeutics (RLAY)
Edgewise Therapeutics (EWTX)
Maze Therapeatics (MAZE)
Bioage Labs Call Option (BIOA)
Inventiva Sa Ads (IVA)
Adlai Nortye Sponsored Ads (ANL)
Compass Pathways Sponsored Ads (CMPS)
Enliven Therapeutics (ELVN)
Rezolute Com New (RZLT)
Arrivent Biopharma Call Option (AVBP)

View all positions for Squadron Capital Management

Top funds holding Proqr Thrapeutics N V shs euro

Adage Capital Partners GP
Standard Life Aberdeen
Affinity Asset Advisors
Privium Fund Management B.V.
Ikarian Capital
Woodline Partners
Heights Capital Management
Sphera Funds Management
Kynam Capital Management
DAFNA Capital Management
Squadron Capital Management
683 Capital Management
Morgan Stanley
Citadel Advisors
Platinum Investment Mangement

View all funds holding Proqr Thrapeutics N V shs euro